Over the last 7 days, the Life Sciences industry has risen 2.4%, driven by gains from Shin Nippon Biomedical Laboratories of 4.8%. During this same period, the Carna Biosciences underperformed, falling 6.6%. In contrast, the industry has lost 34% in the last 12 months. Looking forward, earnings are forecast to grow by 17% annually.
Has the Japanese Life Sciences Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Thu, 02 May 2024 | JP¥183.4b | JP¥62.3b | JP¥3.3b | 14x | 55.7x | 2.9x |
Sat, 30 Mar 2024 | JP¥234.0b | JP¥155.4b | JP¥8.6b | 14x | 27.2x | 1.5x |
Mon, 26 Feb 2024 | JP¥231.3b | JP¥155.3b | JP¥8.7b | 14.7x | 26.6x | 1.5x |
Wed, 24 Jan 2024 | JP¥223.8b | JP¥167.1b | JP¥8.5b | 15.1x | 26.3x | 1.3x |
Fri, 22 Dec 2023 | JP¥223.5b | JP¥167.1b | JP¥8.5b | 14.8x | 26.3x | 1.3x |
Sun, 19 Nov 2023 | JP¥232.3b | JP¥167.6b | JP¥9.0b | 15.1x | 25.9x | 1.4x |
Tue, 17 Oct 2023 | JP¥232.4b | JP¥179.3b | JP¥12.8b | 14.6x | 18.2x | 1.3x |
Thu, 14 Sep 2023 | JP¥265.4b | JP¥179.3b | JP¥12.8b | 15.9x | 20.7x | 1.5x |
Sat, 12 Aug 2023 | JP¥272.4b | JP¥180.0b | JP¥13.7b | 18.3x | 19.9x | 1.5x |
Mon, 10 Jul 2023 | JP¥280.9b | JP¥178.5b | JP¥16.2b | 17.1x | 17.3x | 1.6x |
Wed, 07 Jun 2023 | JP¥287.0b | JP¥178.3b | JP¥16.2b | 17.2x | 17.7x | 1.6x |
Fri, 05 May 2023 | JP¥288.7b | JP¥174.9b | JP¥16.5b | 16.6x | 17.5x | 1.7x |
Sun, 02 Apr 2023 | JP¥306.1b | JP¥171.9b | JP¥13.3b | 17x | 23.1x | 1.8x |
Tue, 28 Feb 2023 | JP¥316.1b | JP¥171.6b | JP¥13.2b | 17.5x | 23.9x | 1.8x |
Thu, 26 Jan 2023 | JP¥295.0b | JP¥166.1b | JP¥16.2b | 15.6x | 18.2x | 1.8x |
Sat, 24 Dec 2022 | JP¥290.8b | JP¥166.1b | JP¥16.2b | 15.6x | 18x | 1.8x |
Mon, 21 Nov 2022 | JP¥318.4b | JP¥165.5b | JP¥16.0b | 15.5x | 19.9x | 1.9x |
Wed, 19 Oct 2022 | JP¥325.0b | JP¥160.1b | JP¥12.4b | 16.5x | 26.3x | 2x |
Fri, 16 Sep 2022 | JP¥330.4b | JP¥160.1b | JP¥12.4b | 18.9x | 26.7x | 2.1x |
Sun, 14 Aug 2022 | JP¥311.2b | JP¥160.1b | JP¥12.9b | 18.3x | 24.2x | 1.9x |
Tue, 12 Jul 2022 | JP¥285.8b | JP¥152.8b | JP¥10.9b | 18x | 26.3x | 1.9x |
Thu, 09 Jun 2022 | JP¥261.0b | JP¥152.7b | JP¥10.9b | 17.9x | 24x | 1.7x |
Sat, 07 May 2022 | JP¥243.3b | JP¥152.3b | JP¥11.4b | 20.3x | 21.4x | 1.6x |
Mon, 04 Apr 2022 | JP¥249.3b | JP¥144.9b | JP¥10.6b | 21.7x | 23.5x | 1.7x |
Wed, 02 Mar 2022 | JP¥254.0b | JP¥144.7b | JP¥10.5b | 19.9x | 24.1x | 1.8x |
Fri, 28 Jan 2022 | JP¥221.6b | JP¥136.0b | JP¥6.8b | 19.8x | 32.8x | 1.6x |
Sun, 26 Dec 2021 | JP¥286.6b | JP¥136.0b | JP¥6.8b | 23.5x | 42.5x | 2.1x |
Tue, 23 Nov 2021 | JP¥348.4b | JP¥135.7b | JP¥6.9b | 27.7x | 50.6x | 2.6x |
Thu, 21 Oct 2021 | JP¥377.6b | JP¥198.7b | JP¥8.1b | 25.9x | 46.8x | 1.9x |
Sat, 18 Sep 2021 | JP¥381.8b | JP¥198.7b | JP¥8.1b | 25.9x | 47.3x | 1.9x |
Mon, 16 Aug 2021 | JP¥344.9b | JP¥201.8b | JP¥5.0b | 24.7x | 68.4x | 1.7x |
Mon, 31 May 2021 | JP¥321.0b | JP¥194.0b | JP¥2.5b | 29.5x | 130.5x | 1.7x |
122.2x
Which industries have driven the changes within the Japanese Healthcare industry?
JP Market | 2.54% | |
Healthcare | 3.26% | |
Life Sciences | 2.42% | |
Clinical Research and Equipment | 2.42% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
2395 Shin Nippon Biomedical Laboratories | JP¥1.54k | 4.8% +JP¥3.0b | -38.8% | PE11.7x | |
130A Veritas In Silico | JP¥1.82k | 9.9% +JP¥1.0b | n/a | n/a | |
2397 DNA Chip Research | JP¥1.16k | 10.3% +JP¥730.9m | 87.3% | PS18.2x | |
4880 CellSource | JP¥1.55k | 1.4% +JP¥415.9m | -38.5% | PE36x | |
2309 CMIC HOLDINGS | JP¥2.64k | 0.2% +JP¥84.5m | 26.6% | PE8.4x |